Chapter/Section Purchase

1 Oral Peptide Therapy Market Overview
1.1 Product Overview and Scope of Oral Peptide Therapy
1.2 Oral Peptide Therapy Segment by Type
1.2.1 Global Oral Peptide Therapy Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Linaclotide
1.2.3 Insulin
1.2.4 Plecanatide
1.2.5 Cyclosporine
1.2.6 Octreotide
1.3 Oral Peptide Therapy Segment by Application
1.3.1 Global Oral Peptide Therapy Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Global Oral Peptide Therapy Market Size Estimates and Forecasts
1.4.1 Global Oral Peptide Therapy Revenue 2017-2028
1.4.2 Global Oral Peptide Therapy Sales 2017-2028
1.4.3 Oral Peptide Therapy Market Size by Region: 2017 Versus 2021 Versus 2028
2 Oral Peptide Therapy Market Competition by Manufacturers
2.1 Global Oral Peptide Therapy Sales Market Share by Manufacturers (2017-2022)
2.2 Global Oral Peptide Therapy Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Oral Peptide Therapy Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Oral Peptide Therapy Manufacturing Sites, Area Served, Product Type
2.5 Oral Peptide Therapy Market Competitive Situation and Trends
2.5.1 Oral Peptide Therapy Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Oral Peptide Therapy Players Market Share by Revenue
2.5.3 Global Oral Peptide Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Peptide Therapy Retrospective Market Scenario by Region
3.1 Global Oral Peptide Therapy Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Oral Peptide Therapy Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Oral Peptide Therapy Market Facts & Figures by Country
3.3.1 North America Oral Peptide Therapy Sales by Country
3.3.2 North America Oral Peptide Therapy Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Oral Peptide Therapy Market Facts & Figures by Country
3.4.1 Europe Oral Peptide Therapy Sales by Country
3.4.2 Europe Oral Peptide Therapy Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oral Peptide Therapy Market Facts & Figures by Region
3.5.1 Asia Pacific Oral Peptide Therapy Sales by Region
3.5.2 Asia Pacific Oral Peptide Therapy Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Oral Peptide Therapy Market Facts & Figures by Country
3.6.1 Latin America Oral Peptide Therapy Sales by Country
3.6.2 Latin America Oral Peptide Therapy Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Oral Peptide Therapy Market Facts & Figures by Country
3.7.1 Middle East and Africa Oral Peptide Therapy Sales by Country
3.7.2 Middle East and Africa Oral Peptide Therapy Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Oral Peptide Therapy Historic Market Analysis by Type
4.1 Global Oral Peptide Therapy Sales Market Share by Type (2017-2022)
4.2 Global Oral Peptide Therapy Revenue Market Share by Type (2017-2022)
4.3 Global Oral Peptide Therapy Price by Type (2017-2022)
5 Global Oral Peptide Therapy Historic Market Analysis by Application
5.1 Global Oral Peptide Therapy Sales Market Share by Application (2017-2022)
5.2 Global Oral Peptide Therapy Revenue Market Share by Application (2017-2022)
5.3 Global Oral Peptide Therapy Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Oral Peptide Therapy Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Allergan Oral Peptide Therapy Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Novo Nordisk
6.2.1 Novo Nordisk Corporation Information
6.2.2 Novo Nordisk Description and Business Overview
6.2.3 Novo Nordisk Oral Peptide Therapy Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Novo Nordisk Oral Peptide Therapy Product Portfolio
6.2.5 Novo Nordisk Recent Developments/Updates
6.3 Synergy Pharmaceuticals ?Salix?
6.3.1 Synergy Pharmaceuticals ?Salix? Corporation Information
6.3.2 Synergy Pharmaceuticals ?Salix? Description and Business Overview
6.3.3 Synergy Pharmaceuticals ?Salix? Oral Peptide Therapy Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Synergy Pharmaceuticals ?Salix? Oral Peptide Therapy Product Portfolio
6.3.5 Synergy Pharmaceuticals ?Salix? Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Oral Peptide Therapy Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novartis Oral Peptide Therapy Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Chiasma
6.5.1 Chiasma Corporation Information
6.5.2 Chiasma Description and Business Overview
6.5.3 Chiasma Oral Peptide Therapy Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Chiasma Oral Peptide Therapy Product Portfolio
6.5.5 Chiasma Recent Developments/Updates
7 Oral Peptide Therapy Manufacturing Cost Analysis
7.1 Oral Peptide Therapy Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oral Peptide Therapy
7.4 Oral Peptide Therapy Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oral Peptide Therapy Distributors List
8.3 Oral Peptide Therapy Customers
9 Oral Peptide Therapy Market Dynamics
9.1 Oral Peptide Therapy Industry Trends
9.2 Oral Peptide Therapy Market Drivers
9.3 Oral Peptide Therapy Market Challenges
9.4 Oral Peptide Therapy Market Restraints
10 Global Market Forecast
10.1 Oral Peptide Therapy Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oral Peptide Therapy by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Oral Peptide Therapy by Type (2023-2028)
10.2 Oral Peptide Therapy Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oral Peptide Therapy by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Oral Peptide Therapy by Application (2023-2028)
10.3 Oral Peptide Therapy Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oral Peptide Therapy by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Oral Peptide Therapy by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer